COVID-19 Patients Admitted to the ICU
Prognostic Factors and Predictors of Mortality in COVID-19 Patients Admitted to the ICU. An Aid for Triage, Counseling, and Resource Allocation
1 other identifier
observational
100
1 country
1
Brief Summary
A retrospective analysis of the adult COVID-19 patients admitted to the ICU. A chart review will be conducted and multiple baseline characteristics, demographics, and treatments given will be recorded. Variables collected will include Age, Gender, BMI, Smoking status, Past medical history, Vital signs on admission, symptoms on admission, duration of symptoms, laboratory results on admission, treatment given. Treatment options will include (Steroids, plasma exchange, IVIG, antibiotics, mode of respiratory support). Primary outcomes will include; Death, duration of ICU stay, duration of mechanical ventilation, in-hospital complications. A regression model will be used to predict poor prognostic factors. Inclusion criteria: patients with confirmed PCR results for COVID-19 AND require ICU admission. Exclusion criteria: those with negative results, pediatric patients and those not requiring ICU admission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 24, 2021
CompletedFirst Posted
Study publicly available on registry
March 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedMarch 25, 2021
March 1, 2021
5 months
March 24, 2021
March 24, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Death
Death Vs No Death
30 day mortality
Duration of ICU stay
Duration of ICU stay
30 days
Duration of mechanical ventilation
The duration the patient required support from a mechanical ventilator
30 days
Secondary Outcomes (1)
In-Hospital complications
30 days
Study Arms (2)
Group 1: Admitted to ICU and died during the hospital stay.
Group 2: Admitted to ICU was were discharged.
Interventions
no intervention will be administered, this is a retrospective observational study.
Eligibility Criteria
Patients presenting to the hospital and suspected of having the COVID-19 virus. Patients who are positive on a PCR test are usually traiged to be managed on the wards Vs ICU (Intensive care unit). This is based on a number of parameters; including but not limited to The severity of the symptoms, vital signs, lab results, co-morbidities, age.
You may qualify if:
- Adults
- Positive PCR test for COVID-19
- Require admission to ICU
You may not qualify if:
- Pediatric patients\\
- Any patient not requiring admission to ICU
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mubarak al Kabeer hospital
Kuwait City, Outside U.S./Canada, 00000, Kuwait
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Waleed burhamah, General surgery resident MKH MB BCH BOA
Study Record Dates
First Submitted
March 24, 2021
First Posted
March 25, 2021
Study Start
January 1, 2021
Primary Completion
June 1, 2021
Study Completion
July 1, 2021
Last Updated
March 25, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share